Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma
暂无分享,去创建一个
Zhaojian Liu | Yanfeng Liu | Zixiang Wang | Jing Wang | Jianping Song | Shourong Wang | J. Qin | Xiangyu Zhai | Donghai Cui | Delin Ma | Bin Jin | Huan Ma
[1] Gang Chen,et al. Therapy for advanced cholangiocarcinoma: Current knowledge and future potential , 2020, Journal of cellular and molecular medicine.
[2] G. Gores,et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management , 2020, Nature Reviews Gastroenterology & Hepatology.
[3] Zhaojian Liu,et al. Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells , 2020, Redox biology.
[4] Yu Deng,et al. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells , 2020, Molecular carcinogenesis.
[5] Zhaojian Liu,et al. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2 , 2020, Cell Death and Disease.
[6] Yen-Yun Wang,et al. DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway , 2019, Annals of Surgical Oncology.
[7] G. Poston,et al. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] J. Tabernero,et al. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer , 2018, Clinical Cancer Research.
[9] K. Iczkowski,et al. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair , 2018, Clinical Cancer Research.
[10] E. J. Lee,et al. Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] M. Renna,et al. High mobility group A1 protein modulates autophagy in cancer cells , 2017, Cell Death and Differentiation.
[12] Y. Pomyen,et al. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. , 2017, Cancer cell.
[13] A. Fusco,et al. High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy , 2017, Molecular carcinogenesis.
[14] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[15] S. Costantini,et al. The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair , 2016, PloS one.
[16] I. Ellis,et al. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein , 2016, Breast Cancer Research and Treatment.
[17] K. Boberg,et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) , 2016, Nature Reviews Gastroenterology &Hepatology.
[18] A. Fusco,et al. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs , 2014, BMC Cancer.
[19] A. Seluanov,et al. Regulation of Rad51 promoter , 2014, Cell cycle.
[20] G. Sauter,et al. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma , 2013, International journal of cancer.
[21] Suyun Huang,et al. FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51 , 2012, Clinical Cancer Research.
[22] L. Cope,et al. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[23] A. Fusco,et al. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma , 2012, Histopathology.
[24] A. Seluanov,et al. Adenoviral Vector Driven by a Minimal Rad51 Promoter Is Selective for p53-Deficient Tumor Cells , 2011, PloS one.
[25] C. Croce,et al. HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents , 2011, Oncogene.
[26] L. Cope,et al. HMGA1 Correlates with Advanced Tumor Grade and Decreased Survival in Pancreatic Ductal Adenocarcinoma , 2009, Modern Pathology.
[27] T. Jacks,et al. p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair , 2009, PLoS genetics.
[28] P. Chieffi,et al. Interaction between HMGA1 and Retinoblastoma Protein Is Required for Adipocyte Differentiation* , 2009, The Journal of Biological Chemistry.
[29] P. Cappabianca,et al. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. , 2009, Cancer research.
[30] R. Reeves,et al. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. , 2007, Cancer research.
[31] Dihua Yu,et al. Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation , 2007, Molecular Cancer Therapeutics.
[32] A. Ashworth,et al. p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene , 2006, EMBO reports.
[33] C. Croce,et al. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death , 2005, Oncogene.
[34] R. Reeves,et al. Inhibition of Nucleotide Excision Repair by High Mobility Group Protein HMGA1* , 2005, Journal of Biological Chemistry.
[35] W. Zhong,et al. High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients , 2005, British Journal of Cancer.
[36] G. D'aiuto,et al. HMGA1 Protein Overexpression in Human Breast Carcinomas , 2004, Clinical Cancer Research.
[37] M. Gonen,et al. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.
[38] A. Brunetti,et al. Transcriptional regulation of human insulin receptor gene by the high‐mobility group protein HMGI(Y) , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] H. Stürzbecher,et al. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma , 2000, Oncogene.
[40] S. Vispé,et al. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. , 1998, Nucleic acids research.